A carregar...
Efficacy and safety of anti-PD-1/anti-PD-L1 antibody therapy in treatment of advanced gastric cancer or gastroesophageal junction cancer: A meta-analysis
BACKGROUND: Faced with limited and inadequate treatment options for patients with advanced gastric cancer or gastroesophageal junction cancer (GC/GEJC), researchers have turned toward, with the support of promising clinical trials, anti-PD-1/anti-PD-L1 antibody therapy. But there are also different...
Na minha lista:
| Publicado no: | World J Gastrointest Oncol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Baishideng Publishing Group Inc
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7667450/ https://ncbi.nlm.nih.gov/pubmed/33250966 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4251/wjgo.v12.i11.1346 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|